Skip to content

Clinical trials

Phase 2/3 Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2/3 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20041
20054
20062
20071
20083
20092
20103
20133
20142
20181
20213
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated7
Unknown status5
Recruiting2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)2
Rottapharm Spain2
Technion, Israel Institute of Technology2
Amit N. Patel MD MS1
Augusta University1
Beni-Suef University1
Cardiol Therapeutics Inc.1
Hemosol1
Isfahan University of Medical Sciences1
Laval University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases36
Atherosclerosis5
Diabetes Mellitus5
Diabetes Mellitus, Type 25
Stroke4
Vascular Diseases4
Hypertension3
Obesity3
Brain Diseases2
Central Nervous System Diseases2

Trials

Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.